Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial - Hu_2015_PLoS.One_10_e0139862 |
Author(s) : Hu C , Tompson D , Magee M , Chen Q , Liu YM , Zhu W , Zhao H , Gross AS , Liu Y |
Ref : PLoS ONE , 10 :e0139862 , 2015 |
Abstract : Hu_2015_PLoS.One_10_e0139862 |
ESTHER : Hu_2015_PLoS.One_10_e0139862 |
PubMedSearch : Hu_2015_PLoS.One_10_e0139862 |
PubMedID: 26465780 |
Title : Platelet aggregation unchanged by lipoprotein-associated phospholipase A inhibition: results from an in vitro study and two randomized phase I trials - Shaddinger_2014_PLoS.One_9_e83094 |
Author(s) : Shaddinger BC , Xu Y , Roger JH , Macphee CH , Handel M , Baidoo CA , Magee M , Lepore JJ , Sprecher DL |
Ref : PLoS ONE , 9 :e83094 , 2014 |
Abstract : Shaddinger_2014_PLoS.One_9_e83094 |
ESTHER : Shaddinger_2014_PLoS.One_9_e83094 |
PubMedSearch : Shaddinger_2014_PLoS.One_9_e83094 |
PubMedID: 24475026 |